Glucose transporter protein Type I (Glut1), when deficient (GlutlDS, OMIM 606777), causes chronic neuroglycopenia and developmental encephalopathy. The deficiency results from GLUT1 haploinsufficiency, genetically transmitted as an autosomal dominant trait. The long-term objectives of this research project are improved understanding of the pathogenesis, increased awareness of the phenotypic presentations, and better treatment of the neurodevelopmental syndrome.
Four specific aims are proposed to achieve these long-term objectives: (1) To expand our understanding of the GlutlDS phenotypes associated with GLUT1 gene mutations; (2) To correlate genotypic pathogenicity with phenotypic severity; (3) To replicate the human disease in an animal model; (4) To explore alternative treatment options for patients with GlutlDS. The research design and methods have been developed to increase recruitment of patients; to assess phenotypic variability by multi-disciplinary methods; and to serially evaluate patients over time to assess the phenotypic durability during development and the influences of gender on clinical expression. The phenotype will be correlated with the genotype by assessing the nature of the mutation and the kinetic and structure-function perturbations that result from these mutations. The Xenopus oocyte expression system is used to evaluate functional disturbances related to missense mutations. GLUT1 polymorphisms will be determined in the GlutlDS population and compared to the presence/absence of similar polymorphisms in a control population. A transgenic antisense mouse model and gene targeted homologous recombination knock-out mouse model will be examined clinically and neuropathologically for evidence of regional brain injury and neuronal apoptosis. Emphasis will be placed on establishing the cellular types most affected by the disease. Cellular dysfunction and apoptosis will be assessed by the in vitro study of neuronal and glial cultures derived from the mutant mouse models. Treatment opportunities will be explored in the mouse models and applied to the patient population assessing the relative benefits of a ketogenic diet and a carbohydrate diet, and the advantages of sustained hyperglycemia using uncooked cornstarch supplements and diazoxide. A 5-hour oral glucose tolerance test will be evaluated as a possible diagnostic tool measuring clinical, neuropsychological and electrographic changes associated with transient hyperglycemia.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS037949-10
Application #
7276032
Study Section
Special Emphasis Panel (ZRG1-BDCN-5 (01))
Program Officer
Tagle, Danilo A
Project Start
1998-08-01
Project End
2009-08-31
Budget Start
2007-09-01
Budget End
2009-08-31
Support Year
10
Fiscal Year
2007
Total Cost
$484,033
Indirect Cost
Name
Columbia University (N.Y.)
Department
Pediatrics
Type
Schools of Medicine
DUNS #
621889815
City
New York
State
NY
Country
United States
Zip Code
10032
Akman, Cigdem Inan; Yu, Julia; Alter, Aliza et al. (2016) Diagnosing Glucose Transporter 1 Deficiency at Initial Presentation Facilitates Early Treatment. J Pediatr 171:220-6
Akman, Cigdem Inan; Provenzano, Frank; Wang, Dong et al. (2015) Topography of brain glucose hypometabolism and epileptic network in glucose transporter 1 deficiency. Epilepsy Res 110:206-15
Pearson, Toni S; Akman, Cigdem; Hinton, Veronica J et al. (2013) Phenotypic spectrum of glucose transporter type 1 deficiency syndrome (Glut1 DS). Curr Neurol Neurosci Rep 13:342
Pong, Amanda W; Geary, Brianna R; Engelstad, Kris M et al. (2012) Glucose transporter type I deficiency syndrome: epilepsy phenotypes and outcomes. Epilepsia 53:1503-10
Yang, Hong; Wang, Dong; Engelstad, Kristin et al. (2011) Glut1 deficiency syndrome and erythrocyte glucose uptake assay. Ann Neurol 70:996-1005
Pons, Roser; Collins, Abbie; Rotstein, Michael et al. (2010) The spectrum of movement disorders in Glut-1 deficiency. Mov Disord 25:275-81
Levy, Brynn; Wang, Dong; Ullner, Paivi M et al. (2010) Uncovering microdeletions in patients with severe Glut-1 deficiency syndrome using SNP oligonucleotide microarray analysis. Mol Genet Metab 100:129-35
Akman, Cigdem I; Engelstad, Kristin; Hinton, Veronica J et al. (2010) Acute hyperglycemia produces transient improvement in glucose transporter type 1 deficiency. Ann Neurol 67:31-40
Rotstein, Michael; De Vivo, Darryl C (2010) Childhood absence epilepsy as a manifestation of GLUT1 deficiency. Ann Neurol 67:272-3; author reply 273
Rotstein, Michael; Engelstad, Kristin; Yang, Hong et al. (2010) Glut1 deficiency: inheritance pattern determined by haploinsufficiency. Ann Neurol 68:955-8

Showing the most recent 10 out of 30 publications